Overview
Aptuit LLC, a leading drug development services company, announced that it has completed the acquisition of InfoPro Solutions, developers of the industry standard Clinicopia® Suite, Clinicambio Data Exchange and the other IT-based, hosted clinical trial materials management solutions.
Under the brand name of Aptuit Informatics, InfoPro Solutions’ experienced professionals will continue to develop, market, and service best-of-breed, mission-critical information systems to support drug developers all over the world.
Significance
The acquisition will enable Aptuit to leverage InfoPro Solutions’ expertise to deploy the industry’s first global, multi-customer, multi-site platform to enable their clients to track details of their drug development projects anywhere in the world, in real time.
The acquisition will enable Aptuit to provide comprehensive solutions to small, virtual, and large global pharmaceutical companies.
The acquisition will immediately enhance Aptuit’s informatics offering by incorporating InfoPro Solutions’ premier clinical information technology systems into Aptuit Informatics’ services and solution offerings.
Crosstree’s Role
Crosstree Capital Partners was the exclusive financial advisor to InfoPro Solutions.
Latest Deals
ROI Healthcare Solutions Acquired by Acuvance, a Portfolio Company of Trinity Hunt
.png)
IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates
.png)
Deep 6 AI Acquired by Tempus
.png)
Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools
.png)
Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business
Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities
Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network
Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network
Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe
.png)
Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US
.V3-1.png)
Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions
%20(1).png)
physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research
.png)
Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities
%20(NEW).png)
Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally
Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering
Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities
Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities
VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities
Grant Avenue Capital Recapitalizes CREO
